Search Results - "Novotna, H"

Refine Results
  1. 1
  2. 2

    Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis by Benešová, Y, Vašků, A, Novotná, H, Litzman, J, Štourač, P, Beránek, M, Kadaňka, Z, Bednařík, J

    Published in Multiple sclerosis (01-03-2009)
    “…Background Matrix metalloproteinases are notable contributors to neuroinflammation and blood-brain barrier disruption in multiple sclerosis (MS). Objective The…”
    Get full text
    Journal Article
  3. 3

    EPA-0888 – Validity of retrospective statements in test and interview of adults with institutional care in childhood by Smetackova, I, Novotna, H, Myskova, L, Onder, J, Kuzelova, H, Ptacek, R

    Published in European psychiatry (2014)
    “…Many research results show problematic nature of retrospective answers (Hardt, Rutter, 2004). Statements based on memories suffer from lower accurate…”
    Get full text
    Journal Article
  4. 4

    EPA-0876 - Quality of relationships of adults with experience of institutional and family care in childhood by Novotna, H, Smetackova, I, Myskova, L, Onder, J, Ptacek, R, Kuzelova, H

    Published in European psychiatry (2014)
    “…The quantitative study deals with the quality of relationships of adults with experience of institutional care during their childhood and compares it to that…”
    Get full text
    Journal Article
  5. 5

    EPA-0855 – Educational trajectory of adults with experience of institutional and family care in childhood by Myskova, L, Smetackova, I, Novotna, H, Onder, J, Kuzelova, H, Ptacek, R

    Published in European psychiatry (2014)
    “…As many studies show, the life of a child in institutional care has a significant influence on his development in different areas of further life. One of the…”
    Get full text
    Journal Article
  6. 6

    Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer by Novotný, Ivo, Dítĕ, Petr, Dastych, Milan, Záková, Anna, Trna, Jan, Novotná, H, Nechutová, H

    Published in Hepato-gastroenterology (01-07-2008)
    “…This study addresses the possibility of very difficult differential diagnosis of pancreatic cancer and chronic pancreatitis, especially in cases where…”
    Get more information
    Journal Article
  7. 7

    Transcriptional Repression of the Microphthalmia Gene in Melanoma Cells Correlates with the Unresponsiveness of Target Genes to Ectopic Microphthalmia-Associated Transcription Factor by Vachtenheim, J., Novotna, H., Ghanem, G.

    Published in Journal of investigative dermatology (01-12-2001)
    “…In the melanocyte, expression of genes required for pigment formation is mediated by the microphthalmia transcription factor, which is also critical for the…”
    Get full text
    Journal Article
  8. 8

    Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas by Vachtenheim, J, Novotná, H

    “…Microphthalmia (MITF) gene product, a transcription factor of the basic-helix-loop-helix type, is thought to play a role in the regulation of genes encoding…”
    Get more information
    Journal Article
  9. 9

    Age-related extracellular to total body water volume ratio (Ecv/TBW)--can it be used for "dry weight" determination in dialysis patients? Application of multifrequency bioimpedance measurement by Lopot, F, Nejedlý, B, Novotná, H, Macková, M, Sulková, S

    Published in International journal of artificial organs (01-08-2002)
    “…The article suggests a novel method for quantitative determination of optimal dry weight in dialysis patient based on their extracellular volume (ECV) to total…”
    Get full text
    Journal Article
  10. 10

    Expression of the aromatic l-amino acid decarboxylase mRNA in human tumour cell lines of neuroendocrine and neuroectodermal origin by Vachtenheim, J, Novotná, H

    Published in European journal of cancer (1990) (01-12-1997)
    “…Neuroendocrine differentiation of lung tumours is characterised by the expression of several neuroendocrine markers and is confined mostly to specific…”
    Get full text
    Journal Article
  11. 11

    Genomic organization and chromosomal mapping of SPARC-like 1, a gene down regulated in cancers by Isler, S G, Schenk, S, Bendik, I, Schraml, P, Novotna, H, Moch, H, Sauter, G, Ludwig, C U

    Published in International journal of oncology (01-03-2001)
    “…Human SPARC-like 1 (SPARCL1), also known as MAST9 or hevin, is a member of the SPARC protein family. Originally we identified SPARCL1 as one of the genes down…”
    Get more information
    Journal Article
  12. 12

    EPA-0867 – Life trajectory and coping strategies in adults with family care and substitute family care childhood experience by Onder, J, Smetácková, I, Novotná, H, Myšková, L, Kuželová, H, Ptácek, R

    Published in European psychiatry (2014)
    “…Nature of early life experiences (especially social-emotional background) has influence on development of coping strategies of each person, which consequently…”
    Get full text
    Journal Article
  13. 13

    Low mutational rate of K-ras codon 12 in singular bronchoscopy specimens in suspected lung cancer by Spasova, I, Novotna, H, Vachtenheim, J, Bartosova, H, Patek, J, Hoserova, V, Zatloukal, P, Kinkor, Z

    Published in Neoplasma (2005)
    “…Mutations of the K-ras gene are found in a subset of non-small- cell lung carcinomas (NSCLC). The aim of our study was to determine the K-ras codon 12 mutation…”
    Get more information
    Journal Article
  14. 14

    Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis by Benesova, Y, Vasku, A, Stourac, P, Hladikova, M, Beranek, M, Kadanka, Z, Novotna, H, Bednarik, J

    Published in Journal of neuroimmunology (15-12-2008)
    “…Abstract We investigated the association of matrix metalloproteinase-9 (− 1562C/T, + 279R/Q) and matrix metalloproteinase-2 (− 1575G/A, − 1306C/T) gene…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Treatment of refractory multiple myeloma with vincristine, adriamycin, dexamethasone, and with repeated application of cyclophosphamide (C-VAD) by Adam, Z, Elbl, L, Vorlicek, J, Hájek, R, Hájek, D, Hejlová, N, Králová, E, Novotná, H

    Published in Acta medica Austriaca (1994)
    “…The quick reduction of differentiated myeloma cells by VAD chemotherapy (vincristine, adriamycin, dexamethasone) causes, according to the investigation by Bell…”
    Get more information
    Journal Article
  18. 18

    Lower cardiotoxicity of adriamycin during continuous administration in patients with refractory multiple myeloma treated with cyclophosphamide, vincristine, adriamycin and dexamethasone (C-VAD) by Adam, Z, Elbl, L, Vorlícek, J, Hájek, R, Tomíska, M, Hejlová, N, Králová, E, Novotná, H

    Published in Vnitřní lékar̆stvĭ (01-08-1994)
    “…Standard treatment of refractory myeloma is combined VAD treatment (vincristine, adriamycin and dexamethasone). In recent years adriamycin was sometimes…”
    Get more information
    Journal Article
  19. 19

    Hypomethylation of CCGG sites in the 3' region of H-ras protooncogene is frequent and is associated with H-ras allele loss in non-small cell lung cancer by VACHTENHEIM, J, HORAKOVA, I, NOVOTNA, H

    Published in Cancer research (Chicago, Ill.) (01-03-1994)
    “…The methylation of MspI/HpaII sites flanking a variable tandem repeat in the 3' region of the c-Ha-ras protooncogene was analyzed in 74 DNA samples of…”
    Get full text
    Journal Article
  20. 20

    Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung by Vachtenheim, J, Horáková, I, Novotná, H, Opáalka, P, Roubková, H

    Published in Clinical cancer research (01-03-1995)
    “…Mutations of the K-ras gene have been implicated in the pathogenesis of human lung adenocarcinomas. In most studies published so far, squamous cell lung…”
    Get full text
    Journal Article